LKQ Stock Cash Flow Statements

LKQ Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

LKQ Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31

cash flows from operating activities:
net income	193,000,000	169,000,000	157,000,000	192,000,000	186,000,000	158,000,000	178,000,000	208,000,000	282,000,000	270,000,000	195,000,000	262,000,000	420,000,000	273,000,000	236,778,000	284,006,000	305,008,000	266,332,000	181,734,000	193,931,000	118,770,000	145,979,000	141,273,000	152,593,000	152,105,000	99,063,000	38,059,000	134,480,000	157,866,000	152,763,000	120,655,000	122,381,000	150,914,000	136,278,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	105,000,000	100,000,000	106,000,000	100,000,000	100,000,000	100,000,000	100,000,000	84,000,000	70,000,000	65,000,000	67,000,000	64,000,000	68,000,000	65,000,000	71,313,000	70,350,000	70,743,000	71,597,000	78,861,000	76,327,000	72,930,000	71,379,000	84,167,000	77,878,000	76,154,000	76,207,000	83,100,000	81,473,000	68,438,000	61,066,000	63,695,000	59,902,000	56,002,000	50,604,000
stock-based compensation expense	9,000,000	8,000,000	8,000,000	6,000,000	8,000,000	8,000,000	11,000,000	9,000,000	10,000,000	10,000,000	7,000,000	8,000,000	10,000,000	13,000,000	8,747,000	8,196,000	9,001,000	7,792,000	6,227,000	7,088,000	7,795,000	7,968,000	6,858,000	7,178,000	7,986,000	5,673,000	5,216,000	5,700,000	5,862,000	5,982,000	5,250,000	5,139,000	5,158,000	7,285,000
other	-3,000,000	2,000,000	17,000,000	9,000,000	24,000,000	33,000,000	-5,000,000	-15,000,000	26,000,000	11,000,000	8,000,000	-13,000,000	-5,000,000	-4,000,000	9,226,000	-21,320,000	-15,314,000	-9,202,000	8,119,000	-8,499,000	-833,000	-2,721,000	-2,991,000	-9,804,000	-3,206,000	-310,000	16,721,000	-11,543,000	7,490,000	-3,134,000	13,283,000	-7,242,000	-6,083,000	1,343,000
changes in operating assets and liabilities, net of effects from acquisitions and dispositions:
receivables	30,000,000	-256,000,000	171,000,000	52,000,000	24,000,000	-249,000,000	159,000,000	69,000,000			102,000,000	68,000,000	44,000,000	-230,000,000	117,533,000	27,567,000	36,260,000	-197,594,000	122,210,000	-23,511,000	58,827,000	-63,938,000	128,800,000	46,671,000	55,977,000	-205,029,000	71,038,000	41,381,000	18,342,000	-130,520,000	19,465,000	22,918,000	10,531,000	-108,893,000
inventories	106,000,000	-86,000,000	-205,000,000	-11,000,000	15,000,000	-52,000,000	-57,000,000	-4,000,000	75,000,000	57,000,000	7,000,000	-90,000,000	-161,000,000	-98,000,000	-181,660,000	-60,138,000	20,753,000	-13,469,000	-102,276,000	89,855,000	453,015,000	-7,522,000	-132,777,000	17,008,000	59,418,000	71,811,000	-56,095,000	-58,281,000	-17,793,000	5,016,000	-106,273,000	-77,206,000	-19,633,000	-745,000
other assets	-2,000,000	-12,000,000
prepaid income taxes/income taxes payable	-6,000,000	38,000,000	-17,000,000	12,000,000	-57,000,000	47,000,000	-37,000,000	30,000,000	-57,000,000	52,000,000	-30,000,000	-11,000,000	14,000,000	60,000,000	-36,371,000	-9,880,000	1,894,000	-20,694,000	57,455,000	-106,635,000	42,540,000	41,585,000	-14,935,000	14,744,000	-16,950,000	42,917,000	-9,387,000	1,172,000	-31,272,000	37,362,000	9,304,000	-5,346,000	-56,646,000	61,064,000
accounts payable	-73,000,000	8,000,000	76,000,000	-5,000,000	-40,000,000	220,000,000	-127,000,000	18,000,000	82,000,000	22,000,000	-109,000,000	-34,000,000	103,000,000	309,000,000	-94,985,000	93,698,000	-46,911,000	331,383,000	41,687,000	66,421,000	-144,970,000	-27,170,000	-87,167,000	-6,009,000	73,597,000	23,291,000	-5,624,000	-46,617,000	-49,304,000	23,924,000	2,961,000	-21,414,000	39,140,000	24,449,000
other liabilities	-62,000,000	26,000,000
operating lease assets and liabilities
net cash from operating activities	296,000,000	-3,000,000	235,000,000	420,000,000	213,000,000	253,000,000	212,000,000	441,000,000	480,000,000	223,000,000	240,000,000	273,000,000	328,000,000	409,000,000	5,019,000	428,938,000	410,578,000	522,512,000	309,229,000	221,589,000	718,489,000	194,563,000	98,862,000	326,767,000	461,179,000	177,225,000	189,572,000	192,498,000	183,506,000	145,163,000	69,657,000	87,146,000	189,804,000	172,293,000
capex	-53,000,000	-54,000,000	-86,000,000	-79,000,000	-80,000,000	-66,000,000	-125,000,000	-97,000,000	-66,000,000	-70,000,000	-74,000,000	-49,000,000	-40,000,000	-59,000,000	-160,761,000	-44,851,000	-46,075,000	-41,779,000	-62,746,000	-32,648,000	-32,763,000	-44,538,000	-100,179,000	-64,283,000	-48,252,000	-53,016,000	-78,264,000	-56,342,000	-53,232,000	-62,189,000	0	-43,992,000	-47,147,000	-44,398,000
free cash flows	243,000,000	-57,000,000	149,000,000	341,000,000	133,000,000	187,000,000	87,000,000	344,000,000	414,000,000	153,000,000	166,000,000	224,000,000	288,000,000	350,000,000	-155,742,000	384,087,000	364,503,000	480,733,000	246,483,000	188,941,000	685,726,000	150,025,000	-1,317,000	262,484,000	412,927,000	124,209,000	111,308,000	136,156,000	130,274,000	82,974,000	69,657,000	43,154,000	142,657,000	127,895,000
cash flows from investing activities:
purchases of property, plant and equipment	-53,000,000	-54,000,000	-86,000,000	-79,000,000	-80,000,000	-66,000,000	-125,000,000	-97,000,000	-66,000,000	-70,000,000	-74,000,000	-49,000,000	-40,000,000	-59,000,000	-160,761,000	-44,851,000	-46,075,000	-41,779,000	-62,746,000	-32,648,000	-32,763,000	-44,538,000	-100,179,000	-64,283,000	-48,252,000	-53,016,000	-78,264,000	-56,342,000	-53,232,000	-62,189,000
acquisitions, net of cash acquired			-3,000,000	-16,000,000	-13,000,000	-17,000,000	-26,000,000	-2,147,000,000	-27,000,000	-25,000,000	0	1,000,000			-57,127,000	-37,291,000	-27,095,000	-2,385,000		-1,642,000	1,755,000	-7,220,000		250,000	-9,982,000	-4,785,000		-70,097,000	-1,133,004,000	-2,966,000	-260,421,000	-151,939,000	-23,672,000	-77,056,000
other investing activities	2,000,000	4,000,000	-6,000,000	-27,000,000	3,000,000	-5,000,000	-15,000,000	-11,000,000	2,000,000	-5,000,000	-2,000,000	-2,000,000	0	-6,000,000	-3,416,000	-14,041,000					-3,512,000	-405,000	-6,115,000	8,103,000	-752,000	17,000	-6,237,000	5,796,000	1,640,000	534,000	11,200,000	-1,962,000	3,398,000	1,314,000
net cash from investing activities	-49,000,000	-50,000,000	-106,000,000	-122,000,000	-90,000,000	-88,000,000	-53,000,000	-2,204,000,000	-88,000,000	-97,000,000	-72,000,000	-21,000,000	328,000,000	-63,000,000	-217,916,000	-91,826,000	-75,573,000	-33,443,000	-59,454,000	-30,462,000	-31,099,000	-44,872,000	-104,764,000	-43,319,000	-58,986,000	-57,784,000	-87,423,000	-122,299,000	-1,184,596,000	-64,621,000	-300,438,000	-197,893,000	-67,421,000	181,157,000
cash flows from financing activities:
borrowings under revolving credit facilities	290,000,000	392,000,000	190,000,000	191,000,000	539,000,000	392,000,000	208,000,000	285,000,000	150,000,000	1,543,000,000	321,000,000	515,000,000	519,000,000	289,000,000	937,350,000	483,949,000	2,325,758,000	1,287,810,000	242,000,000	105,000,000	34,299,000	460,186,000	215,433,000	77,395,000	28,239,000	284,641,000	641,829,000	411,838,000	411,989,000	201,669,000	414,195,000	262,182,000	117,555,000	45,239,000
repayments under revolving credit facilities	-367,000,000	-233,000,000	-237,000,000	-212,000,000	-445,000,000	-659,000,000	-359,000,000	-448,000,000	-264,000,000	-2,003,000,000	-224,000,000	-334,000,000	-783,000,000	-334,000,000	-474,561,000	-449,527,000	-1,400,863,000	-1,392,004,000	-523,539,000	-347,901,000	-466,806,000	-134,674,000	-120,713,000	-142,319,000	-159,100,000	-312,339,000	-418,935,000	-343,438,000	-445,072,000	-321,525,000	-175,593,000	-185,430,000	-196,141,000	-389,313,000
repayments of other debt			-15,000,000	-14,000,000											-7,478,000				-40,787,000	-8,749,000	-16,592,000	-49,481,000		-23,220,000
proceeds from issuance of euro notes (2031), net of unamortized bond discount			0	0	0	816,000,000
repayment of euro notes			0	0	0	-547,000,000									0	0
dividends paid to lkq stockholders	-78,000,000	-78,000,000	-78,000,000	-79,000,000	-80,000,000	-81,000,000	-80,000,000	-74,000,000	-74,000,000	-74,000,000	-74,000,000	-68,000,000	-71,000,000	-71,000,000
purchase of treasury stock	-39,000,000	-40,000,000	-80,000,000	-125,000,000	-125,000,000	-30,000,000	-30,000,000	0	0	-8,000,000	-168,000,000	-344,000,000	-384,000,000	-144,000,000	-302,259,000	-230,755,000	-286,851,000	-56,979,000	-29,286,000	0	0	-88,006,000	0	-101,051,000	-120,300,000	-70,462,000
other financing activities	19,000,000	-12,000,000	-8,000,000	-7,000,000	-5,000,000	-31,000,000	-7,000,000	-4,000,000	0	-6,000,000	-6,000,000	-2,000,000	-4,000,000	-10,000,000	497,000	-3,129,000	-1,612,000	-11,717,000	-2,468,000	-4,604,000	-3,541,000	-7,291,000	-1,173,000	-7,235,000	1,387,000	-1,277,000	2,168,000	-925,000	0	4,107,000	3,000,000	0	-684,000	5,000,000
net cash from financing activities	-209,000,000	40,000,000	-230,000,000	-240,000,000	-163,000,000	-113,000,000	-289,000,000	292,000,000	1,165,000,000	-66,000,000	-177,000,000	-232,000,000	-707,000,000	-278,000,000	80,676,000	-257,104,000	-600,212,000	-208,495,000	-361,768,000	-260,629,000	-555,415,000	-334,739,000	89,025,000	-217,706,000	-339,257,000	-132,731,000	-96,319,000	-75,029,000	1,171,849,000	-117,506,000	234,496,000	76,013,000	-96,690,000	-326,386,000
effect of exchange rate changes on cash, cash equivalents and restricted cash	24,000,000	5,000,000	-30,000,000	11,000,000											3,652,000	-6,005,000	3,713,000	-2,534,000	2,765,000	14,458,000	6,388,000	-11,746,000	8,798,000	-9,600,000	2,411,000	-2,513,000
net increase in cash, cash equivalents and restricted cash	62,000,000	-8,000,000	-131,000,000	69,000,000											-128,569,000	74,003,000	-261,494,000	278,040,000	-109,228,000	-55,044,000			91,921,000	56,142,000
cash, cash equivalents and restricted cash, beginning of period	0	239,000,000																								337,250,000
cash, cash equivalents and restricted cash, end of period	62,000,000	231,000,000	-131,000,000	69,000,000														590,194,000	-109,228,000	-55,044,000	138,363,000	338,063,000	89,779,000	57,186,000	59,975,000	321,447,000
supplemental disclosure of cash paid for:
income taxes, net of refunds	75,000,000	31,000,000	103,000,000	52,000,000	140,000,000	27,000,000	78,000,000	43,000,000	150,000,000	34,000,000		105,000,000	117,000,000	28,000,000										46,997,000	76,226,000	11,775,000		47,995,000	95,281,000	15,464,000	54,687,000	67,777,000	136,809,000	13,746,000
interest	77,000,000	60,000,000	77,000,000	31,000,000	79,000,000	43,000,000	97,000,000	33,000,000	43,000,000	24,000,000		9,000,000	23,000,000	6,000,000										11,266,000	60,797,000	14,462,000		18,649,000	41,793,000	13,975,000	38,188,000	10,913,000	35,641,000	10,965,000
borrowings of other debt		11,000,000				33,000,000																								4,409,000				23,313,000
gain on disposal of businesses
gains on foreign exchange contracts - acquisition related							0	-3,000,000	-23,000,000	-23,000,000
deferred income taxes
proceeds from disposals of businesses, net of divested cash
proceeds from settlement of foreign exchange contracts - acquisition related							0
borrowings under term loans							0	531,000,000	0	500,000,000
proceeds from issuance of u.s. notes (2028/33), net of unamortized bond discount							0	0
cash and cash equivalents, beginning of period					0	299,000,000			0	278,000,000		0	0	274,000,000
other operating assets and liabilities				65,000,000	-47,000,000	-12,000,000	-24,000,000	45,000,000	2,000,000	-5,000,000	-13,000,000	23,000,000	-10,000,000	21,000,000	-98,511,000	36,459,000	5,580,000	86,367,000	-52,402,000	-72,885,000	107,930,000	16,501,000	-35,164,000	30,109,000	22,601,000	9,028,000	-31,632,000	22,018,000	23,877,000	-7,296,000	-10,948,000	-11,986,000	10,421,000	-7,672,000
debt issuance costs				0	-1,000,000	-6,000,000	-1,000,000	-2,000,000	-11,000,000	-19,000,000																	-4,190,000	-179,000	-16,035,000	-724,000
settlement of derivative instruments				6,000,000			0	0							0	0	-31,939,000	-56,804,000
cash and cash equivalents of continuing operations, beginning of period																												0	0	279,766,000	0	0	0	227,400,000
add: cash and cash equivalents of discontinued operations, beginning of period																															0	0	0	7,116,000
cash and cash equivalents of continuing and discontinued operations, beginning of period																												0	0	279,766,000	0	0	0	234,516,000
cash, cash equivalents and restricted cash of continuing and discontinued operations, end of period																			-109,228,000	-55,044,000			91,921,000	56,142,000
less: cash, cash equivalents and restricted cash of discontinued operations, end of period
effect of exchange rate changes on cash and cash equivalents						-7,000,000			5,000,000	4,000,000		-16,000,000	-20,000,000	-6,000,000														974,000	-71,236,000	2,877,000	974,000	6,267,000	13,237,000	3,034,000
net increase in cash and cash equivalents						45,000,000	-125,000,000	-1,480,000,000	1,562,000,000	64,000,000		4,000,000	-62,000,000	53,000,000														-3,856,000	99,523,000	-34,087,000	4,689,000	-28,467,000	38,930,000	30,098,000
cash and cash equivalents, end of period						344,000,000	-102,000,000	-1,503,000,000	1,562,000,000	342,000,000	9,000,000	4,000,000	-62,000,000	327,000,000														-3,856,000	99,523,000	245,679,000	4,689,000	-28,467,000	38,930,000	264,614,000
loss on debt extinguishment																0					0	12,751,000
proceeds from disposals of property, plant and equipment							3,000,000	2,000,000	3,000,000	3,000,000	4,000,000	2,000,000	1,000,000	2,000,000	3,388,000	4,357,000	4,219,000	7,601,000	3,813,000	6,827,000	582,000	5,528,000
proceeds from disposals of businesses											0
early-redemption premium															0	0			0	0	0	-9,498,000
repayments under term loans															0	0	-319,375,000	-4,375,000	-4,375,000	-4,375,000	-4,375,000	-4,375,000	-2,187,000	-2,188,000	-2,187,000	-2,188,000	-240,000,000	-105,990,000	-4,405,000	-4,405,000	0	-9,294,000	-9,295,000	-9,295,000
(repayments) borrowings of other debt								4,000,000						-8,000,000												-625,000	26,965,000	-36,251,000
cash and cash equivalents of continuing and discontinued operations, end of period																															4,689,000	-28,467,000
less: cash and cash equivalents of discontinued operations, end of period																							2,142,000	-1,044,000
receivables, net of allowance for credit losses										-236,000,000
borrowings (repayments) of other debt										1,000,000							13,959,000	25,574,000													-4,816,000	4,931,000
net increase in cash and cash equivalents, including cash classified within current assets held for sale										64,000,000				62,000,000
less: increase in cash classified within current assets held for sale														9,000,000
(gain) on disposal of businesses and impairment of net assets held for sale											0
repayment of u.s. notes																				0	0	-600,000,000
borrowings under receivables securitization facility																			0	0	0	111,300,000	0	0	30,000,000	6,600,000					2,720,000	8,375,000
repayments under receivables securitization facility																			0	0	-98,400,000	-12,900,000	0	0	-109,690,000	-36,910,000					-1,320,000	-4,925,000	-4,850,000	-150,000
proceeds from disposal of businesses																							-1,036,000
impairment of equity method investments
loss on disposal of businesses and impairment of net assets held for sale																				-503,000
gain on debt extinguishment																			0
cash, cash equivalents and restricted cash of continuing operations, beginning of period																		312,154,000	0	0	0	528,387,000	0	0
add: cash, cash equivalents and restricted cash of discontinued operations, beginning of period																			0	0	0	6,470,000
cash, cash equivalents and restricted cash of continuing and discontinued operations, beginning of period																		312,154,000	0	0	0	534,857,000
reconciliation of cash, cash equivalents and restricted cash:
cash and cash equivalents																								57,424,000	59,901,000	316,066,000
restricted cash
supplemental disclosure of noncash investing and financing activities:
noncash property, plant and equipment and software intangible additions in accounts payable and other accrued expenses
notes payable and other financing obligations, including notes issued, debt assumed and settlement of pre-existing balances in connection with business acquisitions and disposals
notes receivable and contingent consideration receivable acquired in connection with disposal of businesses
trade and note receivables forgiven and assets held for sale sold with purchase of noncontrolling interest
notes issued in connection with purchase of noncontrolling interest
contingent consideration liabilities																												3,073,000	0	34,000	0	1,955,000	-6,690,000	10,969,000
the balance as of january 1, 2020 included restricted cash of 5 million.
cash, and cash equivalents of continuing operations, beginning of period
add: cash, and cash equivalents of discontinued operations, beginning of period
cash, and cash equivalents of continuing and discontinued operations, beginning of period
cash, and cash equivalents, end of period
proceeds from disposal of businesses, net of cash sold																		5,944,000	535,000	1,000	2,839,000	1,763,000
investments in unconsolidated subsidiaries																		-2,824,000	-800,000				-700,000				-49,234,000
loss on disposal of businesses and impairment of net assets held for sale and goodwill
acquisitions, net of cash and restricted cash acquired
receipts of deferred purchase price on receivables under factoring arrangements																											27,581,000
redemption of u.s. notes
proceeds from issuance of euro notes																												0
payment of notes issued and assumed debt from acquisitions
payment of notes issued from acquisitions
(gain on disposal of business) and impairment of net assets held for sale																						-249,000
net decrease in cash, cash equivalents and restricted cash																						-196,794,000				-15,803,000
impairment of net assets held for sale and goodwill
impairment of mekonomen equity method investment																								0	0	39,551,000
impairment of net assets held for sale																								-3,601,000	33,497,000	15,023,000
reconciliation of cash, cash equivalents and restricted cash
restricted cash included in other noncurrent assets																								-238,000
stock issued in acquisitions																												0
noncash property, plant and equipment additions																								-7,630,000	5,173,000	9,054,000		4,006,000	2,805,000	4,199,000				2,936,000
notes payable and other financing obligations, including notes issued, debt assumed and settlement of pre-existing balances in connection with business acquisitions																								-109,000
proceeds from exercise of stock options																										1,334,000	1,531,000	850,000	667,000	2,255,000	1,005,000	1,314,000	2,687,000	2,464,000
taxes paid related to net share settlements of stock-based compensation awards																										-1,505,000	-799,000	-934,000	-542,000	-3,292,000	-430,000	-1,140,000	-311,000	-3,644,000
restricted cash included in other assets																										5,381,000
other financing obligations, including debt assumed in connection with business acquisitions																										8,424,000
impairment on mekonomen equity method investment																											48,180,000
impairment of goodwill
loss on sale of business																															2,216,000	0	0	8,580,000
impairment on net assets of discontinued operations
gains on bargain purchases
proceeds from disposals of business/investment																															0	0	0	301,297,000
proceeds from foreign exchange contracts
payment of assumed debt and notes issued from acquisitions
payments of rhiag debt and related payments
payments of other obligations																															2,000	0
notes payable and other financing obligations, including notes issued and debt assumed in connection with business acquisitions/investment
notes and other financing receivables in connection with disposals of business/investment																																0	0	5,848,000
notes payable and other financing obligations, including notes issued and debt assumed in connection with business acquisitions																																46,611,000
purchases of property and equipment																																-43,992,000	-47,147,000	-44,398,000
noncash property and equipment additions																																733,000
gain on foreign exchange contracts - acquisition related
gain on bargain purchase
changes in operating assets and liabilities, net of effects from acquisitions:
effect of exchange rate changes on cash and equivalents
net increase in cash and equivalents
cash and equivalents, beginning of period
cash and equivalents of continuing and discontinued operations, end of period
less: cash and equivalents of discontinued operations, end of period
cash and equivalents, end of period
non-cash property and equipment additions
lkq corporation and subsidiariesconsolidated statements of stockholders’ equity
balance, january 1, 2014
other comprehensive loss
restricted stock units vested
exercise of stock options
tax withholdings related to net share settlements of stock-based compensation awards
excess tax benefit from stock-based payments
balance, december 31, 2014
restricted stock units vested, net of shares withheld for employee tax
balance, december 31, 2015
balance, december 31, 2016
inventory
proceeds from issuance of senior notes
notes payable and other obligations, including notes issued and debt assumed in connection with business acquisitions
balance, january 1, 2013
other comprehensive income
balance, december 31, 2013
prepaid expenses and other assets
accrued expenses and other current liabilities
other noncurrent liabilities
repayments of other long-term debt
balance, january 1, 2012
balance, december 31, 2012
proceeds from sales of property and equipment
investment in unconsolidated subsidiary
borrowings under revolving credit facility
repayments under revolving credit facility
notes payable and long-term obligations, including notes issued in connection with business acquisitions
balance, january 1, 2011
stock issued as director compensation
balance, december 31, 2011
changes in operating assets and liabilities, net of effects from acquisitions and divestitures:
proceeds from sale of businesses, net of cash sold
cash from acquisitions, net of cash acquired
purchase price payable, including notes issued in connection with business acquisitions
stock issued in connection with business acquisitions
debt assumed with business acquisitions
property and equipment acquired under capital leases
property and equipment purchases not yet paid
balance, january 1, 2010
stock issued in business acquisitions
balance, december 31, 2010
amortization of debt issuance costs
gain on sale of discontinued operations
loss on asset impairment
accrued expenses
deferred revenue
borrowings under term loan
supplemental disclosure of cash flow information:
cash paid for income taxes, net of refunds
cash paid for interest
balance, january 1, 2009
unrealized loss on pension plan, net of tax
net reduction of unrealized loss on fair value of interest rate swap agreements, net of tax
foreign currency translation
total comprehensive income
restricted stock granted
balance, december 31, 2009
reversal of unrealized gain on pension plan, net of tax
net reduction of unrealized loss/increase in unrealized gain on fair value of interest rate swap agreements, net of tax
excess tax benefit from share-based payments
repayments under line of credit
borrowings under line of credit
repayments of other long-term debt obligations
balance, january 1, 2008
unrealized gain on pension plan, net of tax
unrealized loss on change in fair value of interest rate swap agreements, net of tax
share price guarantee
stock-based compensation expense—options
activity related to restricted stock awards
balance, december 31, 2008
proceeds from the sale of common stock
retirement of redeemable common stock
notes issued / assumed in connection with business acquisitions
balance, january 1, 2007
reversal of unrealized gain on investment in equity securities, net of tax
purchase and retirement of redeemable common stock
sale of common stock
exercise of stock options, including related tax benefits of 19,257
balance, december 31, 2007
exercise of stock options, including related tax benefits of 12,547
gain on sale of property and equipment
gain on sale of investment securities
excess tax benefit from exercise of stock options
changes in operating assets and liabilities, net of effects from purchase transactions:
proceeds from sale of property and equipment
proceeds from sale of investment securities
repayment of escrow
decrease in restricted cash in escrow
cash from acquisitions
proceeds from exercise of warrants
net borrowings (repayments) under line of credit
(repayments) borrowings under term loans
repayments of long-term debt obligations
notes issued in connection with business acquisitions
notes assumed in connection with business acquisitions
balance, january 1, 2006
unrealized loss on investment in equity securities, net of tax
exercise of stockholder guarantor warrants
exercise of stock options, including related tax benefits of 7,101
balance, december 31, 2006
adjustment for adoption of fin 48
share-based compensation expense
writeoff of debt issuance costs
gain on early extinguishment of debt
gain on interest rate swap
income taxes payable
expenditures for intangible assets
purchase of investment securities
proceeds from conversion of escrow
balance, january 1, 2004
equity-related compensation expense
expiration of warrants issued in acquisitions
exercise of warrants issued in acquisitions
exercise of stock options, including related tax benefits of 1,127
balance, december 31, 2004
unrealized gain on investment in equity securities, net of tax
exercise of stock options, including related tax benefits of 6,210
balance, december 31, 2005

We provide you with 20 years of cash flow statements for LKQ stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of LKQ stock. Explore the full financial landscape of LKQ stock with our expertly curated income statements.

The information provided in this report about LKQ stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.